Search research articles
Contact Us
Filters
Showing results (251-260 of 326) with videos related to
Page
of 33
Sort By:
Chest
|
September 9, 2010
Exhaled nitric oxide in pulmonary diseases: a comprehensive review
Peter J Barnes, Raed A Dweik, Arthur F Gelb, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
February 15, 2026
Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function and fat malabsorption: Report of PROMISE pediatric substudy
Nicole Green, Phuong Vu, Jing Xie, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 14, 2011
Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients
Harriet Corvol, Julie Beucher, Pierre-Yves Boëlle, et al.
The Lancet. Respiratory Medicine
|
October 15, 2014
Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)
Edward F McKone, Drucy Borowitz, Pavel Drevinek, et al.
Pediatric Neurology
|
April 17, 2024
De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia
Lauren A Beslow, Timo Krings, Helen Kim, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 18, 2026
Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children ≥2 years with cystic fibrosis: 96-week interim results from a phase 3 open-label extension study
Jennifer L Goralski, Cori Daines, Jessica E Pittman, et al.
Annals of the American Thoracic Society
|
June 20, 2025
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6 to 11-Year-Olds with Cystic Fibrosis
Jessica E Pittman, Sarah Morgan, Morgan McCreary, et al.
The European Respiratory Journal
|
July 11, 2015
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations
Nicole Sonneveld, Sanja Stanojevic, Reshma Amin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 3, 2014
Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients
Yvonne C W Yau, Felix Ratjen, Elizabeth Tullis, et al.
Physiological Reports
|
May 26, 2022
Non-invasive MR imaging techniques for measuring femoral arterial flow in a pediatric and adolescent cohort
Jessica E Caterini, Kate Rendall, Barbara Cifra, et al.
Page
of 33
Search research articles
Search
Showing results (251-260 of 326) with videos related to
Sort By:
Page
of 33
Chest
|
September 9, 2010
Exhaled nitric oxide in pulmonary diseases: a comprehensive review
Peter J Barnes, Raed A Dweik, Arthur F Gelb, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
February 15, 2026
Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function and fat malabsorption: Report of PROMISE pediatric substudy
Nicole Green, Phuong Vu, Jing Xie, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 14, 2011
Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients
Harriet Corvol, Julie Beucher, Pierre-Yves Boëlle, et al.
The Lancet. Respiratory Medicine
|
October 15, 2014
Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)
Edward F McKone, Drucy Borowitz, Pavel Drevinek, et al.
Pediatric Neurology
|
April 17, 2024
De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia
Lauren A Beslow, Timo Krings, Helen Kim, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 18, 2026
Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children ≥2 years with cystic fibrosis: 96-week interim results from a phase 3 open-label extension study
Jennifer L Goralski, Cori Daines, Jessica E Pittman, et al.
Annals of the American Thoracic Society
|
June 20, 2025
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6 to 11-Year-Olds with Cystic Fibrosis
Jessica E Pittman, Sarah Morgan, Morgan McCreary, et al.
The European Respiratory Journal
|
July 11, 2015
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations
Nicole Sonneveld, Sanja Stanojevic, Reshma Amin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 3, 2014
Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients
Yvonne C W Yau, Felix Ratjen, Elizabeth Tullis, et al.
Physiological Reports
|
May 26, 2022
Non-invasive MR imaging techniques for measuring femoral arterial flow in a pediatric and adolescent cohort
Jessica E Caterini, Kate Rendall, Barbara Cifra, et al.
Page
of 33